Callebaut C, Blanco J, Benkirane N, Krust B, Jacotot E, Guichard G, Seddiki N, Svab J, Dam E, Muller S, Briand J P, Hovanessian A G
Unité de Virologie et Immunologie Cellulaire, ERS 572 CNRS, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France.
J Biol Chem. 1998 Aug 21;273(34):21988-97. doi: 10.1074/jbc.273.34.21988.
The binding of human immunodeficiency virus (HIV) type 1 particles to CD4(+) cells could be blocked either by antibodies against the V3 loop domain of the viral external envelope glycoprotein gp120, or by the V3 loop mimicking pseudopeptide 5[Kpsi(CH2N)PR]-TASP, which forms a stable complex with a cell-surface-expressed 95-kDa protein. Here, by using an affinity matrix containing 5[Kpsi(CH2N)PR]-TASP and cytoplasmic extracts from human CEM cells, we purified three V3 loop-binding proteins of 95, 40, and 30 kDa, which after microsequencing were revealed to be as nucleolin, putative HLA class II-associated protein (PHAP) II, and PHAP I, respectively. The 95-kDa cell-surface protein was also isolated and found to be nucleolin. We show that recombinant preparations of gp120 bind the purified preparations containing the V3 loop-binding proteins with a high affinity, comparable to the binding of gp120 to soluble CD4. Such binding is inhibited either by 5[Kpsi(CH2N)PR]-TASP or antibodies against the V3 loop. Moreover, these purified preparations inhibit HIV entry into CD4(+) cells as efficiently as soluble CD4. Taken together, our results suggest that nucleolin, PHAP II, and PHAP I appear to be functional as potential receptors in the HIV binding process by virtue of their capacity to interact with the V3 loop of gp120.
1型人类免疫缺陷病毒(HIV)颗粒与CD4(+)细胞的结合,既可以被针对病毒外膜糖蛋白gp120的V3环结构域的抗体阻断,也可以被模拟V3环的假肽5[Kpsi(CH2N)PR]-TASP阻断,该假肽能与细胞表面表达的一种95 kDa蛋白形成稳定复合物。在此,我们利用含有5[Kpsi(CH2N)PR]-TASP的亲和基质和人CEM细胞的细胞质提取物,纯化出了三种V3环结合蛋白,分子量分别为95 kDa、40 kDa和30 kDa,经微量测序后发现它们分别是核仁素、假定的HLA II类相关蛋白(PHAP)II和PHAP I。95 kDa的细胞表面蛋白也被分离出来,发现是核仁素。我们发现,重组的gp120制剂能以高亲和力结合含有V3环结合蛋白的纯化制剂,这与gp120与可溶性CD4的结合相当。这种结合可被5[Kpsi(CH2N)PR]-TASP或针对V3环的抗体抑制。此外,这些纯化制剂抑制HIV进入CD4(+)细胞的效率与可溶性CD4相同。综上所述,我们的结果表明,核仁素、PHAP II和PHAP I似乎因其与gp120的V3环相互作用的能力,在HIV结合过程中作为潜在受体发挥作用。